logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
B

Biologics-Targets & Therapy

IF3.4
Papers5
Citations
Journal Papers 5
Publication Date
delete
Oral Acitretin Combined with Topical 0.1% Tretinoin Cream for Facial Basal Cell Carcinoma in an Elderly Patient: A Case Report
deleteBiologics-Targets & Therapy
IF3.4
delete2026-08-14
delete0
deleteOAAI
deleteZhirong Shu; Yu Jiang; Shilin Deng; Tingnan Chen; Jingyao Liang; Xibao Zhang
deleteShare
deleteSave
Hemophagocytic Lymphohistiocytosis Triggered by HSV‑1 in a Patient with Refractory Crohn’s Disease After Long‑Term Sequential Immunosuppressive Therapy
deleteBiologics-Targets & Therapy
IF3.4
delete2026-07-30
delete0
deleteOAAI
deleteLingya Yao; Hanxiao Tu; Qian Cao
deleteShare
deleteSave
Safety Profile of Tozorakimab (an Anti-IL-33 Monoclonal Antibody): Data from the FRONTIER Phase 2 Program
deleteBiologics-Targets & Therapy
IF3.4
delete2026-07-27
delete0
deleteOAAI
deleteRajesh Patel; Dennis Brooks; Elise Gorseth; Rachel Moate; Alexis Hofherr; Chris Kell; Gabriela Luporini Saraiva; Hitesh Pandya; Martin Jenkins; Ioannis Psallidas
deleteShare
deleteSave
Optimization of Recombinant Human Interferon-Gamma Expression and Purification in <em>E. coli</em>; and Developing an Immunization Protocol for the Production of Optimal Humoral Response
deleteBiologics-Targets & Therapy
IF3.4
delete2026-04-16
delete0
deleteOAAI
deleteVanessa Uwituze; Claire M Mugasa; Monica Namayanja; David Paul Nalumenya; Jerome Ndayisenga; Kenneth Ssekatawa; Charles Drago Kato
deleteShare
deleteSave
Net Present Value Impact of FDA's Phase 3 Waivers on Monoclonal Antibody Biosimilar Development
deleteBiologics-Targets & Therapy
IF3.4
delete2026-01-01
delete0
PREAI
deleteRanbhor, Ranjit; Kulkarni, Priyanka
deleteShare
deleteSave